Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases

Details for Australian Patent Application No. 2008251723 (hide)

Owner Deciphera Pharmaceuticals, LLC

Inventors Petillo, Peter A.; Flynn, Daniel L.; Kaufman, Michael D.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008251723

PCT Pub. Number WO2008/140895

Priority 60/913,216 20.04.07 US

Filing date 18 April 2008

Wipo publication date 20 November 2008

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/140895 Priority application(s): WO2008/140895

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008251742-Inhibitors of acetyl-CoA carboxylase for treatment of neuronal hypometabolism

2008251722-Compact fluorescent lamp with outer envelope and method for manufacturing